<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(11)</volume><submitter>Chesneau B</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Pathogenic variants in MYH11 are associated with either heritable thoracic aortic aneurysm and dissection (HTAAD), patent ductus arteriosus (PDA) syndrome, or megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS).&lt;h4>Methods and results&lt;/h4>We report a family referred for molecular diagnosis with HTAAD/PDA phenotype in which we found a variant at a non-conserved position of the 5' donor splice site of intron 32 of MYH11 potentially altering splicing (NM_002474.3:c.4578+3A>C). Although its cosegregation with disease was observed, it remained of unknown significance. Later, aortic surgery in the proband gave us the opportunity to perform a transcript analysis. This showed a skipping of the exon 32, an RNA defect previously reported to be translated to an in-fra</pubmed_abstract><journal>Molecular genetics &amp; genomic medicine</journal><pagination>e1814</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8606209</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus Arteriosus.</pubmed_title><pmcid>PMC8606209</pmcid><pubmed_authors>Khau Van Kien P</pubmed_authors><pubmed_authors>Aubert-Mucca M</pubmed_authors><pubmed_authors>Rolland G</pubmed_authors><pubmed_authors>Lavabre-Bertrand T</pubmed_authors><pubmed_authors>Dulac Y</pubmed_authors><pubmed_authors>Langeois M</pubmed_authors><pubmed_authors>Chesneau B</pubmed_authors><pubmed_authors>Julia S</pubmed_authors><pubmed_authors>Edouard T</pubmed_authors><pubmed_authors>Plaisancie J</pubmed_authors><pubmed_authors>Plancke A</pubmed_authors><pubmed_authors>Marcheix B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus Arteriosus.</name><description>&lt;h4>Background&lt;/h4>Pathogenic variants in MYH11 are associated with either heritable thoracic aortic aneurysm and dissection (HTAAD), patent ductus arteriosus (PDA) syndrome, or megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS).&lt;h4>Methods and results&lt;/h4>We report a family referred for molecular diagnosis with HTAAD/PDA phenotype in which we found a variant at a non-conserved position of the 5' donor splice site of intron 32 of MYH11 potentially altering splicing (NM_002474.3:c.4578+3A>C). Although its cosegregation with disease was observed, it remained of unknown significance. Later, aortic surgery in the proband gave us the opportunity to perform a transcript analysis. This showed a skipping of the exon 32, an RNA defect previously reported to be translated to an in-fra</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-05-09T09:59:54.109Z</modification><creation>2022-02-11T13:22:30.469Z</creation></dates><accession>S-EPMC8606209</accession><cross_references><pubmed>34672437</pubmed><doi>10.1002/mgg3.1814</doi></cross_references></HashMap>